-transparent.png){kind=logo}
A series of new analogues of trifluralin (TFL) were synthesized and characterized in view of changing the unfavorable properties that limits its use as antileishmanial agent. Some of the TFL analogues display more activity than a standard drug (miltefosine) against the promastigote forms of Leishmania infantum and Leishmania donovani and the intracellular form (THP-1 infected with L. infantum). All analogues showed a clear advantage over miltefosine, as they are not hemolytic. Some analogues can conjugate these characteristics with reduced cell toxicity and improved intracellular activity.
Related Publications
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
November 1998,
Journal of medicinal chemistry,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
June 2014,
European journal of medicinal chemistry,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
May 2018,
European journal of medicinal chemistry,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
March 2019,
Bioorganic chemistry,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
February 2018,
Bioorganic & medicinal chemistry letters,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
November 2013,
European journal of medicinal chemistry,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
December 2012,
European journal of medicinal chemistry,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
November 2012,
ChemMedChem,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
October 2012,
Yao xue xue bao = Acta pharmaceutica Sinica,
M A Esteves, and
I Fragiadaki, and
R Lopes, and
E Scoulica, and
M E M Cruz
October 2014,
European journal of medicinal chemistry,
